FPC Investment Advisory’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-55
Closed -$44.6K 156
2024
Q4
$44.6K Buy
55
+43
+358% +$35.6K 0.03% 53
2024
Q3
$10.8K Hold
12
0.01% 38
2024
Q2
$10.9K Hold
12
0.01% 42
2024
Q1
$8.79K Buy
+12
New +$8.54K 0.01% 41

Other funds holding LLY

FPC Investment Advisory's LLY Position: Q1 2025 in Review

FPC Investment Advisory sold out of Eli Lilly (LLY) in Q1 2025, closing a stake of 55 shares — an estimated $44.6K sold.

FPC Investment Advisory first reported a position in LLY in Q1 2024 and held it in 4 quarters. The position peaked at $44.6K in Q4 2024. 3,920 funds tracked by Wall St. Rank hold LLY as of Q1 2025.

  • FPC Investment Advisory reported no remaining Eli Lilly position as of Q1 2025 after selling out during the quarter.
  • FPC Investment Advisory sold 55 Eli Lilly shares in Q1 2025, an estimated $44.6K.
  • FPC Investment Advisory first reported a position in Eli Lilly in Q1 2024 and held it in 4 quarters.
  • FPC Investment Advisory's Eli Lilly position peaked at $44.6K in Q4 2024.
  • 3,920 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2025.

Based on FPC Investment Advisory's 13F filing for Q1 2025, filed 6 May 2025.